Germline Mutations for Kidney Volume in ADPKD-Reference-Cited by-同舟云学术

Germline Mutations for Kidney Volume in ADPKD

Published:2021-12 Issue: Volume: Page:
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Kataoka Hiroshi^ORCID,Yoshida Rie,Iwasa Naomi,Sato Masayo,Manabe Shun,Kawachi Keiko,Makabe Shiho,Akihisa Taro,Ushio Yusuke,Teraoka Atsuko,Tsuchiya Ken,Nitta Kosaku,Mochizuki Toshio^ORCID

Funder

Ministry of Health, Labour and Welfare

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Nephrology

Reference68 articles.

1. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies;Mochizuki;Clin Exp Nephrol,2013

2. Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study;Ushio;Clin Exp Nephrol,2020

3. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD);Uchiyama;Clin Exp Nephrol,2021

4. The importance of total kidney volume in evaluating progression of polycystic kidney disease;Grantham;Nat Rev Nephrol,2016

5. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease [published correction appears in Kidney Int Rep. 2018;3:1015];Perrone;Kidney Int Rep,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Analysis of Severe Polycystic Liver Disease in Japan;Kidney360;2024-05-01

2. The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan;Nephrology;2024-03-10

3. Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease;Journal of Nephrology;2024-02-05

4. Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD;Nephrology Dialysis Transplantation;2023-11-03

5. Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease;Clinical and Experimental Nephrology;2023-06-27